MOTS-c in Dallas–Fort Worth: what the mitochondrial peptide can and can't do for weight loss.

What is MOTS-c, the mitochondrial peptide?

MOTS-c stands for "mitochondrial open reading frame of the 12S rRNA-c." It's a short peptide, 16 amino acids long, coded by a small stretch of DNA inside your mitochondria rather than in the nucleus of the cell.

Mitochondria, the parts of a cell that turn food into energy, carry their own small genome, and researchers have found that a few short sequences in it produce signaling peptides. MOTS-c was reported in 2015 by a team at the University of Southern California (Lee et al., Cell Metabolism), which found that it acts mainly on skeletal muscle and switches on AMPK, an enzyme that acts as a cell's energy sensor and is involved in how muscle takes up and uses glucose.

Later work from the same group showed that under metabolic stress, such as glucose restriction, MOTS-c moves into the cell nucleus and influences which genes are turned on. Natural levels are found in muscle and in blood, and reviews note that circulating levels appear to fall with age.

The product a clinic prescribes is a synthetic copy, MOTS-c acetate, made in a lab and compounded by a licensed pharmacy for one patient. It's one of six peptides Regal can prescribe; see the peptide therapy hub for the others.

Does MOTS-c help with weight loss? What the research shows

Short answer: it's a promising research topic, not a proven weight loss treatment.

MOTS-c, exercise and insulin sensitivity

You'll often see MOTS-c called an "exercise mimetic." Here's where that comes from, and why it's overstated.

Exercise raises your own MOTS-c

A 2021 study in Nature Communications (Reynolds et al.) found that in people, exercise increased MOTS-c in skeletal muscle and in the bloodstream. In mice, MOTS-c treatment, including treatment started late in life, improved physical capacity. That suggests MOTS-c may be one of the signals involved in how exercise benefits muscle.

Insulin sensitivity: interesting in mice, unproven in people

Insulin sensitivity describes how well your cells respond to insulin. When it's poor (insulin resistance), the body needs more insulin to keep blood sugar steady, and losing weight tends to be harder. MOTS-c's best-known animal result is preventing insulin resistance, which is why it gets attention in weight loss circles. But that hasn't been shown in controlled human trials.

What this means for you

• MOTS-c is not a substitute for movement. Regular activity is still the one proven way to raise your own MOTS-c, and it brings benefits no peptide can copy.
• If insulin resistance is your concern, there are treatments with human evidence behind them. Read how semaglutide affects insulin resistance.
• Competitive athletes should check their sport's anti-doping rules before using any peptide.

MOTS-c vs GLP-1s like semaglutide: an honest comparison

People often ask whether MOTS-c is a "natural alternative" to semaglutide or tirzepatide. It isn't. They work differently and sit at very different levels of evidence.

If medication-supported weight loss is your goal, a GLP-1 is the option with the evidence. Learn more about semaglutide for weight loss or how GLP-1 agonists work. Some clients ask about adding MOTS-c alongside a GLP-1; that's a decision for your provider after reviewing your history and medications, and it's never a substitute for the GLP-1, nutrition plan or coaching.

Is MOTS-c legal? The October 2026 HHS policy

On October 28, 2026, the U.S. Department of Health and Human Services issued an enforcement-discretion policy for compounding with six peptide bulk drug substances, including MOTS-c acetate (the notice was published in the Federal Register on October 30). It followed FDA advisory committee review in July 2026. HHS says it doesn't intend to take enforcement action against state-licensed 503A pharmacies, federal facilities or licensed physicians that compound these peptides and meet its conditions.

What the policy is not

• Not FDA approval. HHS's own notice says compounded drugs are not FDA-approved, so the FDA hasn't reviewed their safety, effectiveness or quality.
• Not permanent. It applies while FDA decides through rulemaking which substances belong on the 503A bulks list. HHS can revisit it, for example if a safety signal or quality problem appears, and it isn't binding.
• Not for every product. 503B outsourcing facilities aren't covered, and MOTS-c is covered only in its specified ingredient form and for the routes listed in the policy's appendix: an injection under the skin or into muscle.

Conditions that protect you

Covered products must use bulk ingredient from an FDA-registered facility with a valid certificate of analysis, contain one active ingredient (no blends), carry the label "This is a compounded drug product. Not for resale.", use only an FDA-cleared syringe as a delivery device, and be made for a specific patient's prescription. Serious adverse events must be reported to FDA MedWatch.

MOTS-c side effects, and who shouldn't use it

Because there are no large human trials, there's no reliable list of how often MOTS-c side effects happen, and its long-term safety in people is unknown. What can be said honestly:

• Injection-site reactions such as redness, itching, swelling or tenderness are possible with any injected product.
• Blood sugar: MOTS-c has been studied for effects on glucose metabolism. If you take insulin or other glucose-lowering medication, your provider needs to know before considering it.
• Interactions: how MOTS-c interacts with other medications hasn't been well studied. Tell your provider about every prescription, supplement and other peptide you use.
• Report anything unusual. Any new or worrying symptom should be reported to your provider; serious reactions are reported to FDA MedWatch.

Who shouldn't use MOTS-c

It isn't prescribed during pregnancy or while breastfeeding, because there's no safety data. Your provider will also be cautious, or advise against it, if you have a complex medical history, take several medications that affect blood sugar, or are a competitive athlete subject to drug testing.

How Regal prescribes MOTS-c in Dallas–Fort Worth

MOTS-c at Regal is always an add-on to a weight loss program built on a nutrition plan, weekly coaching and, when appropriate, medication. Here's how it works:

1. Free consultation.Online, by phone or in person at our Mesquite, Fort Worth or Grand Prairie office. You pick the day and time, with no obligation.
2. Medical evaluation.Eric Naifeh, FNP, PMHNP, DC, our medical director, reviews your history, labs and current medications.
3. Your program first.Your plan starts with nutrition, weekly check-ins and, if clinically appropriate, a GLP-1 or other medication.
4. Peptide decision.If you're interested and it's appropriate, your provider explains what MOTS-c can and can't do, and whether, and how, it fits your plan. No dosing is decided before that evaluation.
5. Patient-specific prescription.A licensed pharmacy compounds single-ingredient MOTS-c for you. Whether you search for MOTS-c injections or another form, you receive it in the form and route your provider prescribes, as the policy allows.
6. Ongoing check-ins.Your weekly coaching is where you raise side effects or questions, so your provider can adjust or stop it.

Prefer to stay home? Regal offers virtual visits (video, phone or WhatsApp) anywhere in Texas, and your provider explains how you'll receive your prescription. Compare our weight loss programs to see where peptides fit.